Listed by the USPTO as DEMIE, TIGIST S
Tech Center 3700 • Art Units: 3739 3794 3796
This examiner grants 75% of resolved cases
DEMIE, TIGIST S is a USPTO patent examiner in tech center 3700 and art unit 3739. The profile contains 458 resolved cases, with an allowance rate of 75.1%. The median time to allowance is 1180 days. Interview lift is 20.6%, indicating a useful reported association between interview activity and allowance results.
The principal companies are Boston Scientific Corporation, Covidien L.P., and Abbott Laboratories. The leading firms are SEAGER, TUFTE & WICKHEM, LLP, K&L GATES LLP-Pittsburgh, and Meunier Carlin & Curfman LLC. Practitioners can incorporate interview preparation into a broader strategy for medical-device claims and responses.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18997297 | Systems And Methods For Sizing An Electrode Probe In An Ablation Procedure | Non-Final OA | Stryker Corporation |
| 18913410 | ELECTROSURGICAL FORCEPS FOR GRASPING, TREATING, AND/OR DIVIDING TISSUE | Non-Final OA | Covidien LP |
| 19074127 | MEDICAL DEVICE HAVING A SUPPORT STRUCTURE | Non-Final OA | Boston Scientific Medical Device Limited |
| 19035444 | DEVICES, SYSTEMS, AND METHODS FOR REMOVING MATERIALS FROM A BODY | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18740868 | DEVICES, SYSTEMS, AND METHODS FOR PREVENTING ARCING BETWEEN ELECTRODES FOR MEDICAL PROCEDURES | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18843906 | ELECTROPHYSIOLOGY CATHETER | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 17651609 | DEVICES, SYSTEMS AND METHODS FOR ENDOVASCULAR TEMPERATURE CONTROL | Non-Final OA | ZOLL Circulation, Inc. |
| 18972304 | CATHETER WITH ANGLED IRRIGATION HOLES | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 18272332 | Targeted Temperature Management Systems, Pads, and Methods Thereof | Final Rejection | C. R. Bard, Inc. |
| 19044033 | RF ABLATION SYSTEM WITH FEEDBACK-BASED SPLIT-ELECTRODE GROUND PAD PLACEMENT | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 19115075 | CRYOGENIC ABLATION DEVICE | Non-Final OA | SEDIVENTION GmbH |
| 19041841 | INHALED INTERNAL HEAT/THERMAL CONDUCTION THERAPY FOR ESOPHAGEAL CANCER | Non-Final OA | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.1% of resolved applications examined by Tigist S Demie were allowed (458 resolved cases), compared with 0.0% across Art Unit 3739 over the last five years.
This examiner's interview lift is +20.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Tigist S Demie took 1,180 days on average from filing to allowance.
Tigist S Demie examines applications in Art Unit 3739 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
